225 results
8-K
EX-3.1
AUPH
Aurinia Pharmaceuticals Inc.
12 Sep 24
Aurinia Announces Board Restructuring
4:08pm
therewith duly executed by the registered holder or by his attorney or successor duly appointed, together with such reasonable assurance or evidence
8-K
EX-99.1
AUPH
Aurinia Pharmaceuticals Inc.
1 Aug 24
Aurinia Pharmaceuticals Reports Second Quarter and Six Months 2024 Financial and Operational Results
6:03am
are reasonable, there can be no assurance that the forward-looking information will prove to be accurate.
Forward-looking information by their nature … control. There can be no assurance that forward-looking statements or information will prove to be accurate, as actual results and future events could
DEFA14A
2xr02rxlvvj7fm
4 Jun 24
Additional proxy soliciting materials
5:25pm
8-K
EX-99.1
san b2nd8
2 May 24
Aurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational Results
6:03am
8-K
EX-99.1
j2yf467jh
15 Feb 24
Aurinia Discloses 2023 Year-End Financial and Operational Results, Announces Corporate Actions Focused on Enhancing Shareholder Value
6:06am
8-K
EX-99.1
srydt63lr2n9e al4r
5 Jan 24
Aurinia Provides Preliminary Unaudited Fourth Quarter and Full-year 2023 Net Revenue Results
6:02am
8-K
jqqnzxbp3akbk
5 Jan 24
Aurinia Provides Preliminary Unaudited Fourth Quarter and Full-year 2023 Net Revenue Results
6:02am